Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

New Drug Available to Treat Multidrug-Resistant Tuberculosis

Webpage
New Drug Available to Treat Multidrug-Resistant Tuberculosis

This Medscape CDC Expert Video Commentary features Dr. Sundari Mase discussing multidrug-resistant tuberculosis (MDR TB) and the recently released CDC guidelines for the use and monitoring of a new TB drug called bedaquiline.

Author:

CDC NCHHSTP Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, Division of Tuberculosis Elimination

Topic:

MDR TB, TB Treatment

View Webpage

Related Materials

MMWR: Outbreak of Multidrug - Resistant Tuberculosis at a Hospital - New York City, 1991.

This report summarizes an epidemiologic investigation of TB by hospital infection control, infectious disease, and employee services staff at a New York hospital. It presents information on 32 inpatients, diagnosed during January 1991 to March 1992 with multidrug-resistant Mycobacterium TB (MDR-TB). Of this group, 91 percent died; all were seropositive for HIV. The report also includes information provided by 21 health care workers (HCWs) regularly assigned to the HIV inpatient unit. The HCWs observed that the MDR-TB patients frequently left their rooms to visit other patients, meet visitors, or walk to the day room. Doors to patient rooms in the HIV ward were left open on many occasions. The report findings emphasize the need to fully implement CDC guidelines for preventing TB transmission in health care settings, and to educate clinicians to consider TB in any HIV-infected patients with fever and respiratory symptoms.

Report

Multidrug-Resistant Tuberculosis (MDR TB)

This information sheet discusses multidrug-resistant TB (MDR TB), a strain of TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. It describes TB disease, MDR TB, extensively drug resistant TB (XDR TB), TB transmission, how drug resistance happens, and who is at risk for getting MDR TB. The information sheet also explains how MDR TB can be prevented, TB vaccine, the symptoms of TB disease, and what an individual should do after being exposed to someone with TB.

Information Sheet

Multidrug-Resistant Tuberculosis (MDR TB)

This fact sheet provides an overview of multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB). This fact sheet covers definitions, symptoms, treatment, transmission, and prevention.

Fact Sheet

Global resources for the prevention,
management, and elimination of TB.